News in diabetology 2022

Česká verzia

Authors: Milan Flekač
Authors place of work: Diabetologické centrum VFN v Praze
Published in the journal: Vnitř Lék 2023; 69(4): 270-273
Category: News in...
doi: https://doi.org/10.36290/vnl.2023.051

Summary

The use of new antidiabetic drugs in clinical practice in the last two decades has completely changed the Type 2 diabetes management. Following the results of new clinical trials, international recommendations for the treatment of diabetes were regularly modified. In the field of Type 1 diabetes, new technologies have appeared, such as smart insulin pens. We can await once weekly insulins and dual GLP-1 and GIP analogues in the near future.

Keywords:

SGLT2 inhibitors – heart failure – chronic kidney disease – GLP-1 RA – GIP – weekly insulin – diabetes management consensus

Zdroje

1. Melanie J, Davies J, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 1. November 2022; 45(11):2753–2786.

2. Paluch AE, et al. Daily steps and all‑cause mortality: a meta‑analysis of 15 international cohorts. Lancet Public Health. 2022;7(3):219–228.

3. Solomon SD, et al. DELIVER Trial Committees and Investigators. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022 Sep 22;387(12):1089-1098.

4. Herrington WG, et al. Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jan 12;388(2):117-127.

5. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216.

6. Bajaj HS, et al. Switching to Once‑Weekly Insulin Icodec Versus Once‑Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial. Diabetes Care. 2021 Jul;44(7):1586-1594. doi: 10.2337/dc20-2877.

7. Ekberg NR, et al. Smart pen exposes missed basal insulin injections and reveals the impact on glycemic control in adults with type 1 diabetes. J Diabetes Sci Technol. 2022 Jul 1.